Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe De Block

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Plos One|May 3, 2024
Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanolFrancesca De Ridder, Rie Braspenning, Juan S Ordonez, et al.
Diabetes, Obesity & Metabolism|July 10, 2020
Features of oral glucose tolerance tests in patients after Roux-en-Y gastric bypass with and without hypoglycaemia symptoms in daily life: It's all about speedIlke Mariën, Christophe De Block, An Verrijken, et al.
Diabetes, Obesity & Metabolism|October 20, 2025
Safety and glycaemic control during exercise with the MiniMed™ 780G: A narrative review of evidence from lab to real worldJeremy Basset-Sagarminaga, Christophe De Block, Kirsten Nørgaard, et al.
Contact Dermatitis|August 22, 2025
1,6-Hexanediol Diacrylate, Isocyanates and Other Skin Sensitizers Are Emerging Contact Allergens in Guardian Glucose SensorsElla Dendooven, Fleur Haentjens, Silada Kanokrungsee, et al.
Endocrine|March 1, 2023
A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesityCarlien De Herdt, Christophe De Block, Sven Francque, et al.
Diabetologia|September 13, 2024
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional studyAstrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetes Technology & Therapeutics|March 29, 2021
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World StudyAstrid Lavens, Frank Nobels, Christophe De Block, et al.
Journal of Diabetes Science and Technology|January 30, 2023
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 DiabetesAthena Philis-Tsimikas, Vanita R Aroda, Christophe De Block, et al.
Diabetes, Obesity & Metabolism|February 11, 2025
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomesThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 18, 2021
Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truthNiels Bochanen, Katelijn Decochez, Els Heleu, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Plos One|May 3, 2024
Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanolFrancesca De Ridder, Rie Braspenning, Juan S Ordonez, et al.
Diabetes, Obesity & Metabolism|July 10, 2020
Features of oral glucose tolerance tests in patients after Roux-en-Y gastric bypass with and without hypoglycaemia symptoms in daily life: It's all about speedIlke Mariën, Christophe De Block, An Verrijken, et al.
Diabetes, Obesity & Metabolism|October 20, 2025
Safety and glycaemic control during exercise with the MiniMed™ 780G: A narrative review of evidence from lab to real worldJeremy Basset-Sagarminaga, Christophe De Block, Kirsten Nørgaard, et al.
Contact Dermatitis|August 22, 2025
1,6-Hexanediol Diacrylate, Isocyanates and Other Skin Sensitizers Are Emerging Contact Allergens in Guardian Glucose SensorsElla Dendooven, Fleur Haentjens, Silada Kanokrungsee, et al.
Endocrine|March 1, 2023
A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesityCarlien De Herdt, Christophe De Block, Sven Francque, et al.
Diabetologia|September 13, 2024
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional studyAstrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetes Technology & Therapeutics|March 29, 2021
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World StudyAstrid Lavens, Frank Nobels, Christophe De Block, et al.
Journal of Diabetes Science and Technology|January 30, 2023
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 DiabetesAthena Philis-Tsimikas, Vanita R Aroda, Christophe De Block, et al.
Diabetes, Obesity & Metabolism|February 11, 2025
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomesThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 18, 2021
Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truthNiels Bochanen, Katelijn Decochez, Els Heleu, et al.
Pageof 15